These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 29534580)
1. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation. Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580 [TBL] [Abstract][Full Text] [Related]
2. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer. Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838 [TBL] [Abstract][Full Text] [Related]
3. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486 [TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer. Zhang MX; Wang H; Sun GP Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091 [TBL] [Abstract][Full Text] [Related]
5. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy. Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418 [TBL] [Abstract][Full Text] [Related]
6. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer. Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995 [TBL] [Abstract][Full Text] [Related]
7. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage. Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255 [TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication. Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376 [TBL] [Abstract][Full Text] [Related]
9. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc. Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160 [TBL] [Abstract][Full Text] [Related]
10. E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis. Chong Z; Bao C; He J; Chen T; Zhong L; Li G; Li H; Fang L; Song Y; Fu G; Yang X; Lai L; Liu Y; Wang Q Cell Mol Immunol; 2018 Dec; 15(12):1057-1070. PubMed ID: 30275535 [TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination. Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806 [TBL] [Abstract][Full Text] [Related]
13. Molecular insights and clinical implications for the tumor suppressor role of SCF Qi Y; Rezaeian AH; Wang J; Huang D; Chen H; Inuzuka H; Wei W Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189140. PubMed ID: 38909632 [TBL] [Abstract][Full Text] [Related]
14. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer. Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313 [TBL] [Abstract][Full Text] [Related]
15. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells. Zhao J; Wang Y; Mu C; Xu Y; Sang J Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460 [TBL] [Abstract][Full Text] [Related]
16. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells. Shimizu H; Takeishi S; Nakatsumi H; Nakayama KI JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830867 [TBL] [Abstract][Full Text] [Related]
17. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation. Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870 [TBL] [Abstract][Full Text] [Related]
18. Recent insight into the role of FBXW7 as a tumor suppressor. Yumimoto K; Nakayama KI Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998 [TBL] [Abstract][Full Text] [Related]
19. FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. Saffie R; Zhou N; Rolland D; Önder Ö; Basrur V; Campbell S; Wellen KE; Elenitoba-Johnson KSJ; Capell BC; Busino L Cancer Res; 2020 Jun; 80(12):2498-2511. PubMed ID: 32350066 [TBL] [Abstract][Full Text] [Related]
20. FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. Richter KT; Kschonsak YT; Vodicska B; Hoffmann I Cell Death Differ; 2020 Feb; 27(2):758-772. PubMed ID: 31285543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]